Grifols SA

Grifols SA

Sector: Biological Products Except Diagnostic Substances Region: Spain

: | Spanish Markets: GRF | OTC Markets: GIKLY | Spanish Markets: GRF.P | Nasdaq: GRFS

Similar to: NPS Pharmaceuticals, Inc., BioTime, Inc., ALLENEX AB

Grifols SA operates as a fractionator of plasma derived blood products. The company operates through four segments: Bioessence, Hospital, Diagnostic and Raw Materials. The Bioessence segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by Group companies earmarked for hospital pharmacy. The Diagnostic segment includes the marketing of diagnostic testing equipment, reagents, and other equipment. The Raw Materials segment includes the sale of intermediate biological products and the rendering of manufacturing services to third party companies. The company applies sophisticated science and technology to improve people's health and well-being through providing life-saving products. The company was founded on June 22, 1987 and is headquartered in Barcelona, Spain.

News & Analysis

You may also be interested in: